Glucagon Receptor
Glucagon receptor is a member of the class B G-protein coupled family of receptors and is activated by glucagon, resulting in activation of adenylate cyclase and increased levels of intracellular cAMP.
Products for Glucagon Receptor
- Cat.No. Product Name Information
- GC31322 Adomeglivant (LY2409021) Adomeglivant (LY2409021) (LY2409021) is a potent, selective glucagon receptor (GluR) allosteric antagonist.
- GC25046 Albiglutide Fragment Albiglutide fragment is one copy of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36).
- GC16232 BETP glucagon-like peptide 1 (GLP-1) receptor modulator
- GC39364 Cotadutide acetate Cotadutide (MEDI0382) acetate is a potent dual agonist of glucagon-like peptide-1 (GLP-1) and GCGR with EC50 values of 6.9 pM and 10.2 pM, respectively.
- GC11646 des-His1-[Glu9]-Glucagon (1-29) amide des-His1-[Glu9]-Glucagon (1-29) amide is a potent and peptide antagonist of the glucagon receptor, with a pA2 of 7.2.
- GC16482 Exendin-3 (9-39) amide Exendin-3 (9-39) amide (Exendin (9-39)) is a specific and competitive GLP-1 receptor antagonist.
- GC60829 Exendin-3/4 (59-86) Exendin-3/4 (59-86) is a Exendin-4 peptide derivative.
-
GC13391
Exendin-4
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, mimics the activity of mammalian incretin hormone glucagon-like peptide 1 (GLP-1), and thus, promotes insulin secretion and functions in the control of glucose.
- GC43644 Exendin-4 (acetate) Exendin-4 is a potent peptide agonist of the glucagon-like peptide 1 (GLP-1) receptor (Ki = 136 pM).
- GC34246 FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS is an Exendin-4 peptide derivative.
- GC43761 GLP-1 (1-37) (human, rat, mouse, bovine) (trifluoroacetate salt) GLP-1 (1-37) (human, rat, mouse, bovine) (trifluoroacetate salt) is a highly potent agonist of the GLP-1 receptor.
- GC13743 GLP-1 (9-36) amide antagonist at the human GLP-1 receptor
- GC34244 GLP-1 moiety from Dulaglutide GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist, extracted from patent US 20160369010 A1.
- GC31363 GLP-1 receptor agonist 1 GLP-1 receptor agonist 1 (GLP-1 receptor agonist 1) is a GLP-1 receptor agonist extracted from patent WO2018056453A1, Compound 67.
- GC36147 GLP-1 receptor agonist 2 GLP-1 receptor agonist 2 is a glucagon-like peptide-1 receptor (GLP-1R) agonist.
- GC61545 GLP-1(28-36)amide GLP-1(28-36)amide, a C-terminal nonapeptide of GLP-1, is a major product derived from the cleavage of GLP-1 by the neutral endopeptidase (NEP).
- GC61540 GLP-1(32-36)amide GLP-1(32-36)amide, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1.
- GC33759 GLP-1(7-36) Acetate (Human GLP-1-(7-36)-amide Acetate) GLP-1(7-36) Acetate (Human GLP-1-(7-36)-amide Acetate) is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells.
- GC60876 GLP-1(7-36), amide TFA GLP-1(7-36), amide TFA is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells.
- GC30058 GLP-1(7-37) GLP-1(7-37) is an intestinal insulinotropic hormone that augments glucose induced insulin secretion.
- GC34904 GLP-1(7-37) acetate GLP-1(7-37) acetate is an intestinal insulinotropic hormone that augments glucose induced insulin secretion.
- GC36148 GLP-1R Antagonist 1 GLP-1R Antagonist 1 (compound 5d) is an orally active, CNS penetrant and non-competitive antagonist of glucagon-like peptide 1 receptor (GLP-1R), with an IC50 of 650 nM.
- GC16646 GLP-2 (human) GLP-2(1-33) (human) is an enteroendocrine hormone which can bind to the GLP-2 receptor and stimulate the growth of intestinal epithelium.
- GC13075 GLP-2 (rat) intestinal epithelium-specific growth factor
- GC60877 GLP-2(3-33) GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC50=5.8 nM).
- GC33757 Glucagon (Porcine glucagon) Glucagon (Porcine glucagon) is a peptide hormone, produced by pancreatic α-cells.
- GC15486 glucagon receptor antagonists 1
- GC12569 glucagon receptor antagonists 2
- GC13512 glucagon receptor antagonists 3
- GC19170 Glucagon receptor antagonists-4 Glucagon receptor antagonists-4 is a highly potent, non-peptide and orally active glucagon receptor antagonist.
- GC36150 Glucagon-Like Peptide (GLP) I (7-36), amide, human Glucagon-Like Peptide (GLP) I (7-36), amide, human is a physiological incretin hormone that stimulates insulin secretion.
- GC36152 Glucagon-like peptide 1 (1-37), human (TFA)
-
GC31379
GRA Ex-25
A GCGR antagonist
- GC34245 GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS is an Exendin-4 peptide derivative.
- GC30254 HAEGTFT HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.
- GC31436 HAEGTFTSD HAEGTFTSD is a 9-residue peptide of human GLP-1 peptide or GLP-1(7-36), amide.
- GC31416 HAEGTFTSDVS HAEGTFTSDVS is the first N-terminal 1-11 residues of GLP-1 peptide.
- GC34249 KQMEEEAVRLFIEWLKNGGPSSGAPPPS
- GC17298 L-168,049 human glucagon receptor (hGR) antagonist
- GC31343 LGD-6972 LGD-6972 is a selective and orally active glucagon receptor antagonist.
-
GC10311
Liraglutide
Liraglutide is a highly potent, long-acting GLP-1 receptor agonist (EC50 = 61 pM)and shares 97% of its amino acid sequence identity with human GLP-1 .
- GC31334 Lixisenatide Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).
-
GC10075
Methylprednisolone Sodium Succinate
glucocorticoid
- GC14793 MK 0893
- GC36753 NNC-0640 NNC-0640 is a potent human G-protein-coupled glucagon receptor (GCGR) negative allosteric modulator (NAM) with an IC50 of 69.2 nM.
- GC16969 Oxyntomodulin Endogenous glucagon-like peptide that modulates feeding and metabolism
-
GC38832
PF-06882961
PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R)
- GC38495 Secretin (33-59), rat TFA Secretin (33-59), rat (TFA) is a 27-aa peptide, which acts on secretin receptor, and enhances the secretion of bicarbonate, enzymes, and K+ from the pancreas.
-
GC31404
Semaglutide
Semaglutide is an agonist of the human glucagon-like peptide-1 (GLP-1) receptor.
- GC34328 Semaglutide TFA Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist.
- GC31360 Taspoglutide (ITM077) Taspoglutide (ITM077) is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM.
-
GC34840
Tirzepatide
Tirzepatide, a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, is a prospective therapy for type 2 diabetes mellitus (T2DM).
- GC38133 Tirzepatide (TFA)
-
GC38132
Tirzepatide hydrochloride
Tirzepatide is a dual GIP and GLP-1 receptor agonist capable of inducing GIP and GLP-1 receptor internalization in different ways, with EC50 values of 18.2 nM and 18.1 nM, respectively.
- GC26027 V-0219 V-0219 is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), can be used for obesity-associated diabetes research.
- GC37929 VU0453379 VU0453379 is a highly selective and central nervous system (CNS) penetrant positive allosteric modulator (PAM) of glucagon-like peptide-1R (GLP-1R) with an EC50 of 1.3 μM.
- GC62753 [Des-His1,Glu9]-Glucagon amide TFA [Des-His1,Glu9]-Glucagon amide TFA is a potent and peptide antagonist of the glucagon receptor, with a pA2 of 7.2.
- GC39323 {Val1}-Exendin-3/4 {Val1}-Exendin-3/4 is the first N-terminal 1-28 residues of Exendin-4 peptide.